NCT02555852: Proton Pump Inhibitors and Risk of Community-acquired Pneumonia |
|
|
| Completed | N/A | 4238504 | Canada | esomeprazole, Proton pump inhibitor, omeprazole, pantoprazole, lansoprazole, rabeprazole, cimetidine, histamine-2 receptor antagonist, ranitidine, famotidine, nizatidine, niperotidine, roxatidine, ranitidine bismuth citrate, lafutidine, cimetidine combinations, famotidine combinations | Canadian Network for Observational Drug Effect Studies, CNODES, Drug Safety and Effectiveness Network, Canada, Canadian Institutes of Health Research (CIHR) | Gastroesophageal Reflux Disease (GERD), Community-acquired Pneumonia | 02/12 | 02/12 | | |
